Pliant Therapeutics Stock Price on October 22, 2024

PLRX Stock  USD 13.49  0.15  1.12%   
Below is the normalized historical share price chart for Pliant Therapeutics extending back to June 03, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pliant Therapeutics stands at 13.49, as last reported on the 24th of December, with the highest price reaching 13.49 and the lowest price hitting 13.34 during the day.
IPO Date
3rd of June 2020
200 Day MA
13.1447
50 Day MA
14.0774
Beta
1.087
 
Covid
If you're considering investing in Pliant Stock, it is important to understand the factors that can impact its price. Pliant Therapeutics appears to be not too volatile, given 3 months investment horizon. Pliant Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0825, which implies the firm had a 0.0825% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pliant Therapeutics, which you can use to evaluate the volatility of the company. Please evaluate Pliant Therapeutics' Risk Adjusted Performance of 0.0511, semi deviation of 3.16, and Coefficient Of Variation of 1842.56 to confirm if our risk estimates are consistent with your expectations.
  
At this time, Pliant Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to 6,038 in 2024, whereas Common Stock is likely to drop 3,143 in 2024. . At this time, Pliant Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 2.36 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (6.26). Pliant Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0825

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsPLRX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.12
  actual daily
36
64% of assets are more volatile

Expected Return

 0.34
  actual daily
6
94% of assets have higher returns

Risk-Adjusted Return

 0.08
  actual daily
6
94% of assets perform better
Based on monthly moving average Pliant Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pliant Therapeutics by adding it to a well-diversified portfolio.
Price Book
2.3474
Enterprise Value Ebitda
(2.54)
Price Sales
3.1 K
Shares Float
46.9 M
Wall Street Target Price
40.1818

Related Headline

Madrigal Pharmaceuticals Headline on 22nd of October 2024

Filed transaction by Madrigal Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3

Pliant Therapeutics Valuation on October 22, 2024

It is possible to determine the worth of Pliant Therapeutics on a given historical date. On October 22, 2024 Pliant was worth 14.58 at the beginning of the trading date compared to the closed value of 14.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pliant Therapeutics stock. Still, in general, we apply an absolute valuation method to find Pliant Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pliant Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pliant Therapeutics' related companies.
 Open High Low Close Volume
  15.01    15.18    14.32    14.66    743,015  
10/22/2024
  14.58    14.81    14.21    14.63    220,112  
  14.63    14.65    13.80    14.21    496,371  
Backtest Pliant Therapeutics  |  Pliant Therapeutics History  |  Pliant Therapeutics Valuation   PreviousNext  
Open Value
14.58
14.63
Closing Value
26.94
Upside

Pliant Therapeutics Trading Date Momentum on October 22, 2024

On October 23 2024 Pliant Therapeutics was traded for  14.21  at the closing time. The top price for the day was 14.65  and the lowest listed price was  13.80 . The trading volume for the day was 496.4 K. The trading history from October 23, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.87% . The trading delta at closing time against the current closing price is 3.08% .

Pliant Therapeutics Fundamentals Correlations and Trends

By evaluating Pliant Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pliant Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pliant financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Pliant Therapeutics Stock history

Pliant Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pliant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pliant Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pliant Therapeutics stock prices may prove useful in developing a viable investing in Pliant Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding58.7 M41.1 M
Net Loss-111 M-105.4 M

Pliant Therapeutics Quarterly Net Working Capital

370.08 Million

Pliant Therapeutics Stock Technical Analysis

Pliant Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Pliant Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pliant Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Pliant Therapeutics Period Price Range

Low
December 24, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Pliant Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Pliant Therapeutics December 24, 2024 Market Strength

Market strength indicators help investors to evaluate how Pliant Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pliant Therapeutics shares will generate the highest return on investment. By undertsting and applying Pliant Therapeutics stock market strength indicators, traders can identify Pliant Therapeutics entry and exit signals to maximize returns

Pliant Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Pliant Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Pliant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pliant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Pliant Stock Analysis

When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.